One in five people with cancer participate in medical research studies, Fred Hutchinson Cancer Center study shows.
cancerletter.com/clinical-round…

Fred Hutch's DrJoeUnger recently published two studies highlighting important shifts in eligibility criteria for cancer clinical trials as well as a higher rate of participation than previously known. bit.ly/3xyPWaz

New study published in Journal of Clinical Oncology shows that one in five people with cancer participate in medical research studies. The findings shed light on how policies can further increase access to and participation in #cancerresearch . DrJoeUnger bit.ly/4afTCwH

An important study that sheds light on the contributions of patients to clinical research, which will inform strategies on how to improve trial participation and access. Thank you to the patients and providers who help advance new therapies for people with #cancer .

New study published in Journal of Clinical Oncology shows that one in five people with cancer participate in medical research studies. The findings shed light on how policies can further increase access to and participation in #cancerresearch . DrJoeUnger bit.ly/4afTCwH

New findings show adult #cancer treatment trial participation nationally is 7.1% and >20% of pts contribute to any type of cancer study. Clinical research is a true partnership between #patients and researchers ⁦Mark Fleury⁩ ⁦⁦Fred Hutchinson Cancer Center⁩ ascopubs.org/doi/10.1200/JC…

The ⁦ASCO⁩ ⁦Friends of Cancer Research⁩ ⁦U.S. FDA⁩ recommendations re: #cancer #clinical -trial eligibility criteria has made trials more accessible for pts w/ brain mets. Thks to ⁦Journal of Clinical Oncology⁩ ⁦Dawn Hershman⁩ Hong Xiao, Riha Vaidya ascopubs.org/doi/10.1200/JC…

At #SABCS23 , Dawn Hershman presents on model that uses baseline sociodemographic & financial measures to predict which patients are at significantly higher risk of non-adherence to long-term therapy with aromatase inhibitors. swog.org/news-events/ne… DrJoeUnger The Hope Foundation for Cancer Research

Socioeconomically vulnerable patients with #cancer have better access to the newest treatments in trials following the implementation of the ACA Medicaid Expansion ja.ma/3tJSX62
SWOG Cancer Research Network @Fredhutch DrJoeUnger Dawn Hershman @riharv

Had a wonderful time at the first Moffitt Cancer Center Office of Community Outreach, Engagement & Equity Cancer Health Disparities Grand Rounds with DrJoeUnger from Fred Hutchinson Cancer Center ! Important lessons learned on improving diversity in #oncology clinical trials

“These findings are important for understanding how the sudden propagation of COVID-19 across a population may impact population mortality,' write authors DrJoeUnger of Fred Hutch et al. reut.rs/3Pc67RH

“1.87 million excess deaths occurred among individuals 30 years and older in China during the first 2 months after the end of the zero COVID policy.” Thanks to ⁦JAMA Network Open⁩ ⁦Fred Hutchinson Cancer Center⁩ jamanetwork.com/journals/jaman…

Medicaid pts w/ #cancer have better access to newest treatments in #clinicaltrials after start of ⁦Affordable CareAct. Thks to ⁦Dawn Hershman⁩ ⁦@riharv⁩ ⁦SWOG Cancer Research Network⁩ ⁦American Cancer Society⁩ ⁦⁦The Hope Foundation for Cancer Research⁩ ⁦Fred Hutchinson Cancer Center⁩. jamanetwork.com/journals/jamao…

Socioeconomically vulnerable #cancer patients have better access to the newest treatments in trials following the implementation of the ACA Medicaid Expansion ja.ma/3YLIUsH SWOG Cancer Research Network @Fredhutch DrJoeUnger Dawn Hershman @riharv

💉 'Dynamic Visualization of Adverse Event Data in #Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG Cancer Research Network)' discusses innovative approaches to analyzing clinical trial data 📊. 👉 fal.cn/3yaKe #immunoonc

Population, Clinical, and Scientific Impact of NCI CTEP Clinical Research Dr. Kimryn Rathmell NRG Oncology Alliance for Clinical Trials in Oncology SWOG Cancer Research Network ECOG-ACRIN Cancer Research Group trials have improved patients lives at a low cost. It is important to support them OncoAlert ASCO Journal of Clinical Oncology Nathan A. Pennell MD, PhD, FASCO ascopubs.org/doi/10.1200/JC…

Catch Fred Hutch's DrJoeUnger present 'Sex differences in severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in Cancer clinical trials: An evidentiary perspective' at #AACR23 . See more highlights: bit.ly/41nfRLY SWOG Cancer Research Network

#AACR2023 'Sex differences in severe #adverseevents in pts receiving #immunotherapy , targeted therapy, or chemotherapy in cancer #clinicaltrials : An evidentiary perspective' At major symposium Tues, Apr 18, 1:25 pmET Rm W304 E-H DrJoeUnger Dawn Hershman @FredHutch Columbia Medicine

The National Clinical Trials Network: A Valuable and Undervalued Resource Thoughtful commentary emphasizing value and impact. NCI CTEP Clinical Research Dr. Kimryn Rathmell SWOG Cancer Research Network Journal of Clinical Oncology
ascopubs.org/doi/10.1200/JC…

The impact of National Clinical Trials Network Treatment Studies cannot be overstated. We need sustained investment in this valuable national resource. SWOG Cancer Research Network SWOG Cancer Research NetworkChair National Cancer Institute
ascopubs.org/doi/10.1200/JC…